Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

221.34 +1.94 (+0.89%)

Streaming Delayed Price Updated: 2:55 PM EDT, Aug 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

32 33 34 35 36 37 38 39 Next >

Illumina Insider Sold $1.2M In Company Stock ↗

October 15, 2021

Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4...

Via Benzinga

Topics Regulatory Compliance

Illumina Launches New Employee Resource Group iLatinx During Hispanic Heritage Month

October 14, 2021

SOURCE: Illumina

Via 3BL Media

Illumina Recognized As #20 on Fortune's Change the World List

October 12, 2021

SOURCE: Illumina

Via 3BL Media

Cancer Profiling Market Worth $13.9 Billion by 2025 – Key Players are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US)

October 11, 2021

Via AB Newswire

"Pharmacogenomics Saved My Life"

October 08, 2021

SOURCE: Illumina

Via 3BL Media

Topics Product Recall

Global Nuclease Market: What Are the Key Trends in Market? with Top Companies Like: MercK, Illumina, Thermo Fisher Scientific

October 07, 2021

The global Nuclease market is extensively evaluated by seasoned research analysts to help readers to expand their market knowledge and become aware of future market changes ahead of time.

Via SBWire

Topics Initial Public Offering

Illumina Celebrates International Equal Pay Day

September 17, 2021

SOURCE: Illumina

Via 3BL Media

Why Shares of Ilumina Slumped 11.3% in September ↗

October 06, 2021

The company's merger with GRAIL concerned investors.

Via The Motley Fool

SBTi Validates and Approves Illumina's Climate Action Targets

October 06, 2021

SOURCE: Illumina

Via 3BL Media

Topics Emissions

San Diego Squared Announces 2021 STEM Educators Awards Recipients

October 05, 2021

SOURCE: Illumina

Via 3BL Media

Illumina's Sustainability Efforts Rewarded With Gold Rating From EcoVadis

October 01, 2021

SOURCE: Illumina

Via 3BL Media

Bioinformatics Market Worth $21.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™ ↗

September 30, 2021

The global bioinformatics market is projected to reach $21.8 billion by 2026. Bioinformatics platforms market report provides crucial industry insights that will help your business grow.

Via SBWire

Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation

September 29, 2021

SOURCE: Illumina

Via 3BL Media

Microfluidics Market Worth $58.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™ ↗

October 04, 2021

Microfluidics Market categorizes the global market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics),...

Via SBWire

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

September 28, 2021

Some trends will persist for decades.

Via The Motley Fool

Illumina's Spotlight on Ovarian Cancer: Understanding Tumors Through Comprehensive Genomic Profiling

September 27, 2021

SOURCE: Illumina

Via 3BL Media

On World Cancer Research Day, Illumina Highlights the Transformative Power of Genomics

September 24, 2021

SOURCE: Illumina

Via 3BL Media

Topics Artificial Intelligence Death

Cancer Diagnostics Market Worth $26.6 Billion by 2026 – Growing Focus on Personalized Medicine and Leading Key Players ↗

September 24, 2021

The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5% during the forecast period

Via SBWire

For the Fourth Consecutive Year, Illumina Was Recognized As a Platinum Tier SANDAG iCommute Diamond Award Winner

September 22, 2021

SOURCE: Illumina

Via 3BL Media

Topics Emissions

Illumina Begins Climate Week by Highlighting How Sequencing Supports Resilient Responses to Climate Change

September 20, 2021

SOURCE: Illumina

Via 3BL Media

Topics Climate Change Death

Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle

September 15, 2021

SOURCE: Illumina

Via 3BL Media

Next-generation Sequencing (NGS) Market worth $24.2 billion by 2026 | Key Players are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US)

September 14, 2021

Via AB Newswire

UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types ↗

September 13, 2021

Britain's National Health Service (NHS) will begin the world's largest trial of Grail Inc's flagship Galleri blood test that can be used to detect...

Via Benzinga

Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™ ↗

September 13, 2021

The global single-cell analysis market is projected to reach $6.3 billion by 2026. Single cell data analysis market report provides crucial industry insights that will help your business grow.

Via SBWire

Illumina Named #1 for Workers in Its Industry by JUST Capital

September 10, 2021

SOURCE: Illumina

Via 3BL Media

Genomics Market worth $54.4 billion by 2025 | Key Players are Illumina, Inc. (US),Thermo Fisher Scientific (US) QIAGEN N.V. (Netherlands)

September 09, 2021

Via AB Newswire

Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050

September 09, 2021

SOURCE: Illumina

Via 3BL Media

Topics Climate Change Emissions

Illumina, Inc. (NASDAQ:ILMN) Investor Alert: Investigation over Possible Violations of Securities Laws ↗

September 08, 2021

San Diego, CA -- (SBWIRE) -- 09/08/2021 -- Illumina, Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research Assay ↗

September 07, 2021

Illumina Inc (NASDAQ: ILMN) and Merck & Co Inc (NYSE: MRK) provided more details on their partnership to develop and commercialize tests that gauge...

Via Benzinga

Why Illumina Wants Grail Back So Badly ↗

September 04, 2021

The gene-sequencing giant sees a huge opportunity in diagnostics.

Via The Motley Fool

< Previous 1 2

...

32 33 34 35 36 37 38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.